News for hackers. Stuff that matters.
Re:Survival of HIV+ patients starting antiretroviral therapy... by caio1982 on Thursday May 11, 2017 @01:05PM (#14317588)
I wonder how the results would change if they had considered countries like Brazil, which offers a cocktail of ~17 drugs for free for everyone HIV positive since 1996 (when patents were fought in the supreme court IIRC). Many americans and europeans (also japanese) come here every year to get some of these medicines for a fraction of what they would cost back home.
Re:Survival of HIV+ patients starting antiretroviral therapy... by arcticfox on Thursday May 11, 2017 @02:48PM (#14318505)
I'm not a big fan of drug company profits (and the patents that provide them), but to be fair, I wonder how the results would change without American- and European-developed drugs.
Re:Survival of HIV+ patients starting antiretroviral therapy... by aantix on Thursday May 11, 2017 @02:52PM (#14318546)
It costs a company 2.5 billion to bring a new drug to market. https://www.scientificamerican.com/article/cost-to-develop-n...

With all of the countries mandating fixed pricing, America subsidizes the rest of the world.

Take away profits, you take away the company's ability to bring Rx to market or do new research.

No one pays their fair share for this research, except the U.S.

Re:Survival of HIV+ patients starting antiretroviral therapy... by jonahhorowitz on Thursday May 11, 2017 @03:07PM (#14318654)
This would be more plausible if the companies in question spent more on R&D than marketing. Also, there are plenty of other ways to fund drug research besides the exorbitant system we use today.
Re:Survival of HIV+ patients starting antiretroviral therapy... by aantix on Thursday May 11, 2017 @03:29PM (#14318780)
It's a typical engineering fallacy that if you build it they will come.

The public, including doctors, have so much information to consume that if they aren't re-educated on treatment choices the drug will die and so too may the company.

Advertising is absolutely critical in recouping R&D costs. And that's assuming the drug makes it to market (which a majority do not).

>In the United States, it takes an average of 12 years for

>an experimental drug to travel from the laboratory to your

>medicine cabinet. That is, if it makes it. Only 5 in 5,000

>drugs that enter preclinical testing progress to human

>testing. One of these 5 drugs that are tested in people is

>approved.

Re:Survival of HIV+ patients starting antiretroviral therapy... by dikdik on Thursday May 11, 2017 @08:25PM (#14320583)
No, doctors do not have "too much information to consume" especially in relation to new drugs on the market.

In the highly specialized field of medicine, you do not need to know about every drug that comes out every year. You only need to know about the handful of drugs that are important to your specialty. Further physicians should be reading medical literature regarding the efficacy of these new drugs and should not be getting their education from a pharmacy rep with a bachelors in communication.

This idea that we wouldn't have any new drugs if American's didn't pay exorbitant fees for pharamaceuticals is completely false. It's a rationalization that we Americans have come up with to feel better about being taken to the cleaners by pharma companies.

I had the displeasure of working for a company that was bought out by a multi-national pharma. The crap they pulled disgusted me to the point that I quit without another job lined up. If you think contributing to a company that improves click rates is pointless, try contributing to a company that uses its leverage to eviscerate its customers on their deathbeds. It's infuriarating.

Re:Survival of HIV+ patients starting antiretroviral therapy... by favorited on Thursday May 11, 2017 @06:07PM (#14319917)
For the record, the US is one of the only Western countries where drug companies are allowed to market directly to consumers.
Re:Survival of HIV+ patients starting antiretroviral therapy... by marcosdumay on Thursday May 11, 2017 @05:24PM (#14319670)
Educating doctors is not a job for the pharma companies.
Re:Survival of HIV+ patients starting antiretroviral therapy... by pulse7 on Thursday May 11, 2017 @06:27PM (#14320021)
The funny part is: this "education" often happens on turist attractive locations like remote islands where doctors can come with their families... and pharma companies pay the costs... sad reality...
Re:Survival of HIV+ patients starting antiretroviral therapy... by refurb on Thursday May 11, 2017 @03:42PM (#14318863)
That's incorrect and based on an analysis that lumps all sales and general expenses into "marketing".

Also, companies don't market unless it brings in more revenue than it costs (positive ROI). Thus, marketing pays for itself. They wouldn't do it otherwise.

Re:Survival of HIV+ patients starting antiretroviral therapy... by joewrong on Thursday May 11, 2017 @03:15PM (#14318710)
> CSDD’s finding, a bellwether figure in the drug industry, is based on an average out-of-pocket cost of $1.4 billion and an estimate of $1.2 billion in returns that investors forego on that money during the 10-plus years a drug candidate spends in development.

the estimate includes money that investors could have made if they invested elsewhere?

Re:Survival of HIV+ patients starting antiretroviral therapy... by aantix on Thursday May 11, 2017 @03:29PM (#14318784)
Opportunity costs are real. Promising hypotheses are abundant and cheap. Exploring each with grueling, resource-intense, high-standard science is expensive.

You have to make hard choices.

Re:Survival of HIV+ patients starting antiretroviral therapy... by throwaway18917 on Thursday May 11, 2017 @03:14PM (#14318709)
Society would collectively decide to fund drug development because it betters all of humanity. There are ways to innovate without fucking over everyone for the sake of profit, you know.
Re:Survival of HIV+ patients starting antiretroviral therapy... by orbifold on Thursday May 11, 2017 @03:35PM (#14318819)
Then you have to solve a very difficult resource allocation problem. Capitalism solved it with a distributed scalable universal reward mechanism (profit). At least in European societies drug discovery is then still financed by society because there exists universal healthcare, which is subsidized by the state for underprivileged people.
Re:Survival of HIV+ patients starting antiretroviral therapy... by aantix on Thursday May 11, 2017 @03:41PM (#14318852)
Profitability funds the next generation of drugs. It pays the salaries of researchers and clinicians and funds human trials.

E.g. A drug like Kadcyla that gives six months to late stage breast cancer patients. 20 years ago that option wasn't available but now it is an option, in part, due to profits of other drugs.

[dead]
Re:Survival of HIV+ patients starting antiretroviral therapy... by dang on Friday May 12, 2017 @01:46AM (#14321695)
> Nothing in life is free, asshole

Commenting like this is a bannable offense on Hacker News. Please (re)-read the site rules, and please don't post uncivilly again.

https://news.ycombinator.com/newsguidelines.html

https://news.ycombinator.com/newswelcome.html

We detached this subthread from https://news.ycombinator.com/item?id=14318709 and marked it off-topic.

Re:Survival of HIV+ patients starting antiretroviral therapy... by iamleppert on Friday May 12, 2017 @05:36PM (#14328136)
The basis of my comment was civil, and I only used profanity to illustrate my argument; as it was written it is not an attack on the OP, to which I apologize if I offended.

It's actually a quote/reference from the movie "The Score" during the hacking scene. I forgot to quote it and provide the reference, my bad..

And if you ban my account, I'll just make another one.

Re:Survival of HIV+ patients starting antiretroviral therapy... by bryondowd on Thursday May 11, 2017 @05:07PM (#14319524)
I'd say few people try to maximize compensation. Rather, most people prioritize on a number of factors including not just compensation, but enjoyment/tolerance of the work. And compensation generally becomes less of a priority as it increases, as there's less need for it.

In other words, it's not clear that you need to maximize profits to get a respectable amount of human resources into a field. Capitalism is great at many things, but there's definitely cases where common cause makes other solutions more viable within a limited scope.

Also, in response to why other countries aren't funding drug development, it could be as simple as the fact that they don't need to, since the US is doing it for them. Similar to the effect of our outsized military spending allowing many allied countries to spend less on their own defense.

Re:Survival of HIV+ patients starting antiretroviral therapy... by Joeri on Thursday May 11, 2017 @05:11PM (#14319556)
Ah, snatched defeat from the jaws of victory with the closing sentence.

Most people aren't gung ho compensation maximizers, otherwise nobody would work in education or government. Free-market capitalism has so far been the most successful economic model, but that doesn't mean it's the right approach for everything. You might be surprised how many drugs are developed by government research institutes.

Besides, why shouldn't human rights, like healthcare, be free? Well, ok, taxpayer-funded is not quite the same as free, but the idea still has merit. Can we really say we deserve this planet if we don't even take care of our own? Desperately wanting to fit everything into a free market model has so far produced more problems than it solved.

Re:Survival of HIV+ patients starting antiretroviral therapy... by peter303 on Thursday May 11, 2017 @04:38PM (#14319294)
"I dont have to practice safe sex, because there is pill for it" As this article shows the pill doesnt always work.